Choice of Infusion Solution in the Perioperative Period
Abstract
Recently, the topic of discussion in the world literature is the general problems of infusion therapy, as well as the application of crystalloid and synthetic colloid solutions in clinical practice. At the same time, the role of 0.9% sodium chloride and balanced solutions is being actively studied [2.4.5.9.11.14.16.20.23.27.30.35-43]. Several studies have shown that saline solutions in infusion therapy affect the electrolyte balance of human blood plasma and are poorly understood by practicing physicians. Incorrect determination of saline solutions leads to changes in the patient's homeostasis and deterioration of clinical outcomes.
References
Albert RK. Chloride-restrictive fluid administration and incidence of acute kidney injury. Journal of the American Medical Association. 2013;309(6):542.
Annane D, Siami S, Jaber S, Martin C, Elatrous S, Declere AD, Trouillet JL. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. Journal of the American Medical Association. 2013;310(17):1809-1817.
Asfar P, Schortgen F, Boisrame-Helms J, Charpentier J, Guerot E, Megarbane B, Henry-Lagarrigue M. Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial. The Lancet Respiratory Medicine. 2017;5(3):180-190.
Barbier C, Loubieres Y, Schmit C, Hayon J, Ricome JL, Jardin F, Vieillard- Baron A. Respiratory changes in inferior vena cava diameter are helpful in predicting fluid responsiveness in ventilated septic patients. 2023 Intensive Care Medicine. 2004;30(9):1740-1746.
Barker P, Creasey PE, Dhatariya K, Levy N, Lipp A, Nathanson MH, Woodcock T. Peri‐operative management of the surgical patient with diabetes 2015: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia. 2015; 70(12):1427-1440.
Bechir M, Puhan MA, Neff SB, Guggenheim M, Wedler V, Stover JF, Stocker R, Neff TA. Early fluid resuscitation with hyperoncotic hydroxyethyl starch 200/0.5 (10%) in severe burn injury. Critical Care. 2010;14(3):R123.
Boussekey N, Darmon R, Langlois J, Alfandari S, Devos P, Meybeck A, Leroy O. Resuscitation with low volume hydroxyethylstarch 130 kDa/0,4 is not associated with acute kidney injury. Critical Care. 2010;14(2):R40.
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine. 2008;358(2):125-139.
Edwards MR, Mythen MG. Fluid therapy in critical illness. Extreme Physiology & Medicine. 2014;3(1):16.
El Gkotmi N, Kosmeri C, Filippatos TD, Elisaf MS. Use of intravenous fluids/ solutions: a narrative review. Current Medical Research and Opinion.2017;33(3):459-471.
Finfer S., Vincent JL. Resuscitation Fluids. New England Journal of Medicine. 2013;369:669-670.
Garzotto F, Ostermann M, Martin-Langerwerf D, Sanchez-Sanchez M, Teng J, Robert R, Kipnis E. The dose response multicentre investigation on fluid assessment (DoReMIFA) in critically ill patients. Critical Care. 2016; 20(1):196.
Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, Van Aken H. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0,9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Critical Care. 2012;16(3):R94.
Guilabert P, Usua G, Martin N, Abarca L, Barret JP, Colomina MJ. Fluid resuscitation management in patients with burns: update. British Journal of Anaesthesia. 2016;117(3):284-296.
Hohl MK, Luscher KP, Tichy J, Stiner M, Fridrich R, Gruber UF, Kaser O. Prevention of postoperative thromboembolism by dextran 70 or low-dose heparin. Obstetrics and Gynecology. 1980;55(4):497-500.
Jha S, Prabhu D. Is normal saline really ≪normal≫? International Journal of Critical Illness and Injury Science. 2013;3(2):161.
Kayilioglu SI, Dinc T, Sozen I, Bostanoglu A, Cete M, Coskun F. Postoperative fluid management. World Journal of Critical Care Medicine. 2015;4(3):192-201.
Krajewski ML, Raghunathan K, Paluszkiewicz SM, Schermer CR, Shaw AD. Metaanalysis of high‐versus low‐chloride content in perioperative and critical care fluid resuscitation. British Journal of Surgery. 2015;102(1):24-36.
Kruger K, Seifart W, Freudenberg R. Infusion incidents with dextran. Anaesthesiologie und Reanimation. 1988;13(5):259.
Kirov MYu, Kuzkov VV. Osnovy intensivnoj terapii i anesteziologii v schema i tablicah (uchebnoe posobie, izdanie 5-e, pererabotannoe i dopolnennoe). Arkhangelsk. 2016. (In Russ.).
Lamke LO, Liljedahl SO. Plasma volume changes after substitution with various
infusion solutions. Lakartidningen. 1977;74(15):1486-1489.
Laxenaire MC, Charpentier C, Feldman L. Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study. In Annales Francaises d’Anesthesie et de Reanimation. 1994;13(3):301-310.
Li H, Sun SR, Yap JQ, Chen JH, Qian Q. 0,9% saline is neither normal nor physiological. Journal of Zhejiang University-Science B. 2016;17(3):181-187.
Lundsgaard-Hansen P, Tschirren B. Clinical experience with 120,000 units of modified fluid gelatin. Developments in Biological Standardization. 1980; 48:251-256.
Marx G, Schindler AW, Mosch C, Albers J, Bauer M, Gnass I, Maurer T. Intravascular volume therapy in adults: Guidelines from the Association of the Scientific Medical Societies in Germany. European Journal of Anaesthesiology. 2016;33(7):488-521.
Matheson NA, Diomi P. Renal failure after the administration of dextran 40. Surgery, Gynecology & Obstetrics. 1970;131(4):661.
McCluskey SA, Karkouti K, Wijeysundera D, Minkovich L, Tait G, Beattie WS. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesthesia & Analgesia. 2013;117(2):412-421.
Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SA; CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine. 2012;367(20):1901-1911.
National Institute for Clinical Excellence. Intravenous fluid therapy in adults in hospital. NICE clinical guideline; 2013.
Navarro LHC, Bloomstone JA, Auler JOC, Cannesson M, Della Rocca G, Gan TJ, Perel A. Perioperative fluid therapy: a statement from the international Fluid Optimization Group. Perioperative Medicine. 2015;4(1):3.
Powell-Tuck J, Allison SP, Gosling P, Lobo DN, Carlson GL, Gore M, Mythen MG. Summary of the British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients (GIFTASUP). London: NHS National Library of Health; 2009.
Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. The Cochrane Library. 2013.
Perner A, Haase N, Guttormsen A.B, Tenhunen J, Klemenzson G, Aneman A, Bendtsen A. Hydroxyethyl starch 130/0.42 versus Ringer‘s acetate in severe sepsis. New England Journal of Medicine. 2012;367(2):124-134.
Rasmussen KC, Hoejskov M, Johansson PI, Kridina I, Kistorp T, Salling L, Nielsen HB, Ruhnau B, Pedersen T, Secher NH. Coagulation competence for predicting perioperative hemorrhage in patients treated with lactated Ringer’s vs. Dextran — a randomized controlled trial. BMC Anesthesiology. 2015;15(1):178.
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Rochwerg B. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Medicine. 2017;43(3):304-377.
Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, Neugebauer EA. The European guideline on management of major bleeding and coagulopathy following trauma. Critical Care. 2016;20(1):100.
Serrano AB, Candela-Toha AM, Zamora J, Vera J, Muriel A, Del Rey JM, Liano F. Preoperative hydration with 0,9% normal saline to prevent acute kidney injury after major elective open abdominal surgery: a randomised controlled trial. European Journal of Anaesthesiology (EJA). 2016;33(6):436-443.
Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA. Major complications, mortality, and resource utilization after open abdominal surgery: 0,9% saline compared to Plasma-Lyte. Annals of Surgery. 2012;255(5):821-829.
Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesthesia & Analgesia. 2013;116(1):35-48.
Vincent JL. No room for hyperoxia or hypertonic saline in septic shock. The Lancet Respiratory Medicine. 2017;5(3):158-159.
Wan S, Roberts MA, Mount P. Normal saline versus lower-chloride solutions for kidney transplantation. Cochrane Database of Systematic Reviews. 2013;8.
Wise R, Faurie M, Malbrain ML, Hodgson E. Strategies for intravenous fluid resuscitation in trauma patients. World Journal of Surgery. 2017;41(5):1170-1183.
Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. Journal of the American Medical Association. 2012;308(15):1566-1572.
Zazzeron L, Gattinoni L, Caironi P. Role of albumin, starches and gelatins versus crystalloids in volume resuscitation of critically ill patients. Current Opinion in Critical Care. 2016;22(5):428-436
Keywords
synthetic colloid
homeostasis Настой
синтетический коллоид
гомеостаз İnfuzion
sintetik kolloid
homeostaz
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.